Vagus nerve stimulation for drug‐resistant epilepsy: A European long‐term study up to 24 months in 347 children

Abstract

The results demonstrate that adjunctive VNS Therapy in children with drug-resistant epilepsy reduces seizure frequency and is well tolerated over a 2-year follow-up period. No new safety issues were identified. A post hoc analysis revealed a dose-response correlation for VNS in patients with epilepsy.